Athenex Inc (ATNX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

1001 MAIN STREET BUFFALO, NY 14203

Founded in 2003, Athenex, Inc. is a global clinical stage biopharmaceutical company dedicated to becoming a leader in the discovery, development, and commercialization of next generation drugs for the treatment of cancer. Athenex is organized around three platforms, including an Oncology Innovation Platform, a Commercial Platform, and a Global Supply Chain Platform. The Company's current clinical pipeline is derived from four different platform technologies: (1) Orascovery, based on P-glycoprotein inhibitor, (2) Src kinase inhibition, (3) T-cell receptor-engineered T-cells (TCR-T), and (4) Arginine deprivation therapy. Athenex's employees worldwide are dedicated to improving the lives of cancer patients by creating more active and tolerable treatments. Athenex has offices in Buffalo and Clarence, New York; Cranford, New Jersey; Houston, Texas; Chicago, Illinois; Hong Kong; Taipei, Taiwan; multiple locations in Chongqing, China; Manchester, UK; Guatemala City, Guatemala and Buenos Aires, Argentina.

Data as of 2021-09-26 20:57:15 -0400
Market Cap351.971 Million Shares Outstanding109.308 Million Avg 30-day Volume1.644 Million
P/E Ratio-2.417 Dividend Yield0.0 EPS-1.56
Price/Sales3.18 Debt to Equity2.21 EBITDA-131.641 Million
Price to Book Value2.07 Forward PE Enterprise Value402.349 Million
Total Cash130.224 Million Current Debt62.923 Million Gross Profit41.387 Million
BETA0.2736 52-week High/Low15.0 / 3.12 Next Earnings Date2021-11-04 Price to Cash FLow (P/CF) -12.4788
Data provided by IEX Cloud
View SEC Filings from ATNX instead.

View recent insider trading info

Funds Holding ATNX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ATNX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

50 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WU JINN

  • Director
683,208 2021-09-14 4

LAU JOHNSON YIU NAM CEO AND CHAIRMAN OF THE BOARD

  • Officer
  • Director
8,161,895 2021-08-17 12

CAMPBELL KIM

  • Director
136,000 2021-08-03 3

YORDON JEFFREY SEE REMARKS

  • Officer
798,926 2021-08-03 1

VIERLING JOHN

  • Director
43,750 2021-08-03 2

PEDDER SIMON SEE REMARKS

  • Officer
375,310 2021-08-03 1

ZUO WILLIAM WEI PRESIDENT, CHINA DIVISION

  • Officer
312,884 2021-08-03 2

SPIEGEL ROBERT J.

  • Director
24,792 2021-08-03 1

FOK MANSON

  • Director
3,192,824 2021-08-03 1

KWAN RUDOLF EVP, CHIEF MEDICAL OFFICER

  • Officer
1,365,648 2021-08-03 2

TSANG BENSON KWAN HUNG

  • Director
77,250 2021-08-03 1

DAVIS STEPHANIE A

  • Director
72,500 2021-08-03 1

KANFER JORDAN

  • Director
47,134 2021-08-03 1

BAIR TERESA BROPHY GENERAL COUNSEL, SVP ADMIN.

  • Officer
313,000 2021-08-03 1

ADAMS STEVEN J. INTERIM CHIEF ACCT OFFICER

  • Officer
0 2021-08-03 2

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • 10% Owner
13,532,467 2020-09-14 0

SZE RANDOLL CHIEF FINANCIAL OFFICER

  • Officer
6,000 2020-09-10 0

KOH JOHN

  • Director
No longer subject to file 2020-06-05 0

TRAINOR-DEGIROLAMO SHELDON

  • Director
No longer subject to file 2019-03-14 0

ZHANG SONG-YI

  • Director
5,197,668 2019-03-11 0

ZHANG SONG-YI

MANDRA MEDICAL LTD

BEANSPROUTS LTD

MUI BING HOW TAMMY

  • Director
  • 10% Owner
6,422,189 2018-08-23 0

SHEN LI SEE REMARKS.

  • Officer
200 2018-01-01 0

CANNON MICHAEL D

0 2017-06-19 0

RIEHLE J NICK CHIEF FINANCIAL OFFICER

1,500 2017-06-19 0

ZUKIN JAMES

0 2017-06-19 0

LEUNG ANTONY

2,103,028 2017-06-19 0

MA HUATENG

ADVANCE DATA SERVICES LTD

  • 10% Owner
6,444,032 2017-06-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

WU JINN - Director

2021-09-14 17:05:42 -0400 2021-09-14 P 50,000 $3.22 a 403,208 direct 5.0147 -2.3599 5.0147 2 -2.3599 6

LAU JOHNSON YIU NAM - Director - Officer CEO AND CHAIRMAN OF THE BOARD

2021-08-17 16:31:28 -0400 2021-08-17 A 3,000 $3.23 a 3,250,959 direct -3.3435 6.6869 6.9909 4 -3.3435 2

ZUO WILLIAM WEI - Officer PRESIDENT, CHINA DIVISION

2021-08-05 16:46:47 -0400 2021-08-03 A 12,500 a 12,500 direct

ADAMS STEVEN J. - Officer INTERIM CHIEF ACCT OFFICER

2021-08-17 16:28:28 -0400 2021-08-03 A 12,500 a 12,500 direct

KANFER JORDAN - Director

2021-08-05 17:17:40 -0400 2021-08-03 A 7,500 a 7,500 direct

DAVIS STEPHANIE A - Director

2021-08-05 17:22:51 -0400 2021-08-03 A 8,750 a 8,750 direct

KWAN RUDOLF - Officer EVP, CHIEF MEDICAL OFFICER

2021-08-05 17:14:45 -0400 2021-08-03 A 70,000 a 70,000 direct

BAIR TERESA BROPHY - Officer GENERAL COUNSEL, SVP ADMIN.

2021-08-05 17:26:56 -0400 2021-08-03 A 37,500 a 37,500 direct

LAU JOHNSON YIU NAM - Director - Officer CEO AND CHAIRMAN OF THE BOARD

2021-08-05 17:11:37 -0400 2021-08-03 A 150,000 a 150,000 direct

SPIEGEL ROBERT J. - Director

2021-08-05 17:04:30 -0400 2021-08-03 A 8,750 a 8,750 direct

TSANG BENSON KWAN HUNG - Director

2021-08-05 17:02:07 -0400 2021-08-03 A 10,000 a 10,000 direct

VIERLING JOHN - Director

2021-08-05 16:58:43 -0400 2021-08-03 A 7,500 a 7,500 direct

WU JINN - Director

2021-08-05 16:54:25 -0400 2021-08-03 A 7,500 a 7,500 direct

ADAMS STEVEN J. - Officer INTERIM CHIEF ACCT OFFICER

2021-08-17 16:28:28 -0400 2021-08-03 A 12,500 a 12,500 direct

FOK MANSON - Director

2021-08-05 17:21:19 -0400 2021-08-03 A 6,250 a 6,250 direct

DAVIS STEPHANIE A - Director

2021-08-05 17:22:51 -0400 2021-08-03 A 8,750 a 8,750 direct

CAMPBELL KIM - Director

2021-08-05 17:24:07 -0400 2021-08-03 A 7,500 a 7,500 direct

BAIR TERESA BROPHY - Officer GENERAL COUNSEL, SVP ADMIN.

2021-08-05 17:26:56 -0400 2021-08-03 A 37,500 a 37,500 direct

PEDDER SIMON - Officer SEE REMARKS

2021-08-05 17:07:49 -0400 2021-08-03 A 30,000 a 30,000 direct

SPIEGEL ROBERT J. - Director

2021-08-05 17:04:30 -0400 2021-08-03 A 8,750 a 8,750 direct

YORDON JEFFREY - Officer SEE REMARKS

2021-08-05 16:49:25 -0400 2021-08-03 A 50,000 a 50,000 direct

VIERLING JOHN - Director

2021-08-05 16:58:43 -0400 2021-08-03 A 7,500 a 7,500 direct

ZUO WILLIAM WEI - Officer PRESIDENT, CHINA DIVISION

2021-08-05 16:46:47 -0400 2021-08-03 A 12,500 a 12,500 direct

KANFER JORDAN - Director

2021-08-05 17:17:40 -0400 2021-08-03 A 7,500 a 7,500 direct

FOK MANSON - Director

2021-08-05 17:21:19 -0400 2021-08-03 A 6,250 a 6,250 direct

KWAN RUDOLF - Officer EVP, CHIEF MEDICAL OFFICER

2021-08-05 17:14:45 -0400 2021-08-03 A 70,000 a 70,000 direct

CAMPBELL KIM - Director

2021-08-05 17:24:07 -0400 2021-08-03 A 7,500 a 7,500 direct

LAU JOHNSON YIU NAM - Director - Officer CEO AND CHAIRMAN OF THE BOARD

2021-08-05 17:11:37 -0400 2021-08-03 A 150,000 a 150,000 direct

PEDDER SIMON - Officer SEE REMARKS

2021-08-05 17:07:49 -0400 2021-08-03 A 30,000 a 30,000 direct

TSANG BENSON KWAN HUNG - Director

2021-08-05 17:02:07 -0400 2021-08-03 A 10,000 a 10,000 direct

YORDON JEFFREY - Officer SEE REMARKS

2021-08-05 16:49:25 -0400 2021-08-03 A 50,000 a 50,000 direct

WU JINN - Director

2021-08-05 16:54:25 -0400 2021-08-03 A 7,500 a 7,500 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ATHENEX INC ATNX 2021-09-27 22:15:03 UTC -0.3292 0.3992 1100000
ATHENEX INC ATNX 2021-09-27 21:45:03 UTC -0.3292 0.3992 1100000
ATHENEX INC ATNX 2021-09-27 21:15:03 UTC -0.3292 0.3992 1100000
ATHENEX INC ATNX 2021-09-27 20:45:04 UTC -0.3292 0.3992 1100000
ATHENEX INC ATNX 2021-09-27 20:15:03 UTC -0.3292 0.3992 1100000
ATHENEX INC ATNX 2021-09-27 19:45:03 UTC -0.3292 0.3992 1100000
ATHENEX INC ATNX 2021-09-27 19:15:03 UTC -0.3292 0.3992 1100000
ATHENEX INC ATNX 2021-09-27 18:45:02 UTC -0.3292 0.3992 1100000
ATHENEX INC ATNX 2021-09-27 18:15:03 UTC -0.3292 0.3992 1100000
ATHENEX INC ATNX 2021-09-27 17:45:03 UTC -0.3292 0.3992 1100000
ATHENEX INC ATNX 2021-09-27 17:15:04 UTC -0.3292 0.3992 1100000
ATHENEX INC ATNX 2021-09-27 16:45:03 UTC -0.3365 0.4065 1100000
ATHENEX INC ATNX 2021-09-27 16:15:03 UTC -0.3365 0.4065 1100000
ATHENEX INC ATNX 2021-09-27 15:45:03 UTC -0.3365 0.4065 1100000
ATHENEX INC ATNX 2021-09-27 15:15:03 UTC -0.3365 0.4065 1100000
ATHENEX INC ATNX 2021-09-27 14:45:02 UTC -0.4139 0.4839 1100000
ATHENEX INC ATNX 2021-09-27 14:15:03 UTC -0.4139 0.4839 1100000
ATHENEX INC ATNX 2021-09-27 13:45:03 UTC -0.4139 0.4839 1100000
ATHENEX INC ATNX 2021-09-27 13:15:03 UTC -0.4139 0.4839 2100000
ATHENEX INC ATNX 2021-09-27 12:45:04 UTC -0.4139 0.4839 2100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments